|
Children 6 months to <2 years The recommended dose of ZYRTEC syrup in children 6 months to 23 months of age is 2.5 mg (˝ teaspoon) once daily. The dose in children 12 to 23 months of age can be increased to a maximum dose of 5 mg per day, given as ˝ teaspoonful (2.5 mg) every 12 hours. Dose Adjustment for Renal and Hepatic Impairment Text Continues Below

In patients 12 years of age and older with decreased renal function (creatinine clearance 11-31 mL/ min), patients on hemodialysis (creatinine clearance less than 7 mL/ min), and in hepatically impaired patients, a dose of 5 mg once daily is recommended. Similarly, pediatric patients aged 6 to 11 years with impaired renal or hepatic function should use the lower recommended dose. Because of the difficulty in reliably administering doses of less than 2.5 mg (˝ teaspoon) of ZYRTEC syrup and in the absence of pharmacokinetic and safety information for cetirizine in children below the age of 6 years with impaired renal or hepatic function, its use in this impaired patient population is not recommended. HOW SUPPLIED
ZYRTEC® tablets are white, film-coated, rounded-off rectangular shaped containing 5 mg or 10 mg cetirizine hydrochloride. 5 mg tablets are engraved with "ZYRTEC" on one side and "5" on the other. Bottles of 100: NDC 0069-5500-66 10 mg tablets are engraved with "ZYRTEC" on one side and "10" on the other. Bottles of 100: NDC 0069-5510-66 STORAGE: Store at 20 ° ° ° -25 ° ° ° C (68 ° ° ° -77 ° ° ° F) excursions permitted to 15 -30 C (59 -86 F) [see USP Controlled Room Temperature]. ZYRTEC® syrup is colorless to slightly yellow with a banana-grape flavor. Each teaspoonful (5 mL) contains 5 mg cetirizine hydrochloride. ZYRTEC® syrup is supplied as follows: 120 mL amber glass bottles NDC 0069-5530-47 1 pint amber glass bottles NDC 0069-5530-93 STORAGE: Store at 20 ° ° ° -25 ° ° ° C (68 ° ° ° -77 ° ° ° F) excursions permitted to 15 -30 C (59 -86 F) [see USP Controlled Room Temperature]; or Store refrigerated, 2 ° ° ° -8 ° ° ° C (36 ° ° ° -46 ° ° ° F). Cetirizine is licensed from UCB Pharma, Inc. Rx only 2003 PFIZER INC Manufactured/ Marketed by Marketed by UCB Pharma, Inc. Smyrna, GA 30080 70-4573-00-7 Revised August 2003 Pfizer Labs Division of Pfizer Inc, NY, NY 10017 Page: << Prev | 1 | 2
|